Royal Biologics, a leading manufacturer and distributor of orthobiologic and regenerative medicine solutions has announced the U.S. commercial launch of Maxx™ Ultra Cord, a maximum natural thickness allograft derived from umbilical cord.
HACKENSACK, N.J. (PRWEB) SEPTEMBER 16, 2019
Royal Biologics, a leading manufacturer and distributor of orthobiologic and regenerative medicine solutions today has announced the U.S. commercial launch of Maxx™ Ultra Cord, a maximum natural thickness allograft derived from umbilical cord. Maxx™Ultra Cord provides an alternative from traditional placental layer membrane allografts by providing up to 8X thicker membrane options that can be sutured and offers excellent handling characteristics. Maxx Ultra Cord will join Royal Biologics’ robust portfolio of traditional and signature allograft products used to treat and heal a variety of conditions in multiple specialties.
Salvatore Leo, Chief Executive Officer of Royal Biologics states, “With the addition of Maxx™ Ultra Cord Royal Biologics will now offer a wide variety of allograft products used to treat various potential clinical applications such as spine & neurosurgery, foot & ankle, wound care and dermatology. We are excited to announce the U.S. commercial launch of Maxx Ultra Cord and are looking forward to continuing to bring multiple solution options to surgeons needs.”
Maxx™ Ultra Cord will be the first umbilical derived allograft to join Royal Biologics birth tissue portfolio which include its Amnio-Maxx™ family of traditional single and double layer Amniotic Placental allografts and Amnio Maxx RT and Cyro, its placental fluid based allograft options.
“We feel that with the addition of Maxx™ Ultra Cord, Royal Biologics will now offer one of the most expansive birth tissue portfolios in the industry. We have multiple options, sizes and variations to fit the needs of our customers.” – Salvatore Leo, CEO.
About Royal Biologics, LLC
Royal Biologics is a leading medical device and biologics company located in Hackensack, NJ. The company sells branded and licensed orthobiologics and stem cell therapy devices, and serves as the sales representatives for multiple spinal implant hardware product lines. Some of Royal’s branded products include Maxx-Cell, a proprietary bone marrow aspirate needle, and Amnio-Maxx, amniotic fluid and / or dual layered tissue used in spine and orthopedic procedures to promote wound healing and the regeneration of healthy tissue. For more information, please visit https://royalbiologics.com/
“We feel that with the addition of Maxx™ Ultra Cord, Royal Biologics will now offer one of the most expansive birth tissue portfolios in the industry. We have multiple options, sizes and variations to fit the needs of our customers.” – Salvatore Leo, CEO.
